An innovative and efficient reagent- and scaffold-based diversity oriented synthesis (DOS) of a fragment set was developed for fragment-based drug discovery (FBDD) programs. Twelve diverse, functionalized and bicyclic scaffolds were rapidly accessed by adopting a convenient synthetic toolkit around three privileged azine cores in order to effectively modulate biomolecules. These structures are characterized by both key motifs for interacting with diverse biological targets via hydrogen bonds and useful points of growth for subsequent fragment optimization
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
This thesis explores two approaches to fragment-based drug discovery. First, protein target CK2 was ...
The productive exploration of chemical space is an enduring challenge in chemical biology and medici...
An innovative and efficient reagent- and scaffold-based diversity oriented synthesis (DOS) of a frag...
Synthesising polar semi-saturated bicyclic heterocycles can lead to better starting points for fragm...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
Current fragment sets tend to be dominated by flatter molecules, and their shape diversity does not ...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
The impressive advances in the ability of organic and medicinal chemists to efficiently prepare lib...
In the interdisciplinary research field of chemical biology and drug discovery, diversity-oriented s...
How can diversity-oriented strategies for chemical synthesis provide chemical tools to help shape o...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
From Europe PMC via Jisc Publications RouterHistory: ppub 2020-10-01, epub 2020-10-07Publication sta...
Identifying innovative fragments for drug design can help medicinal chemistry address new targets an...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
This thesis explores two approaches to fragment-based drug discovery. First, protein target CK2 was ...
The productive exploration of chemical space is an enduring challenge in chemical biology and medici...
An innovative and efficient reagent- and scaffold-based diversity oriented synthesis (DOS) of a frag...
Synthesising polar semi-saturated bicyclic heterocycles can lead to better starting points for fragm...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
Current fragment sets tend to be dominated by flatter molecules, and their shape diversity does not ...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
The impressive advances in the ability of organic and medicinal chemists to efficiently prepare lib...
In the interdisciplinary research field of chemical biology and drug discovery, diversity-oriented s...
How can diversity-oriented strategies for chemical synthesis provide chemical tools to help shape o...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
From Europe PMC via Jisc Publications RouterHistory: ppub 2020-10-01, epub 2020-10-07Publication sta...
Identifying innovative fragments for drug design can help medicinal chemistry address new targets an...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
This thesis explores two approaches to fragment-based drug discovery. First, protein target CK2 was ...
The productive exploration of chemical space is an enduring challenge in chemical biology and medici...